One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
What Are Microfluidic Platforms?November 10, 2023Microfluidic platforms are a powerful and innovative technology that is revolutionizing a wide range of industries. These platforms are designed to handle and process small amounts of fluids, often on...view
Knowledge About Transcriptome SequencingDecember 1, 2022In a broad sense, the transcriptome refers to the collection of all transcripts in a cell under a certain physiological condition, including messenger RNA, ribosomal RNA, transfer RNA and non-coding R...view
Microfluidic Chips: What Do You Know?April 4, 2023Microfluidic chip technology integrates the basic operational units of sample preparation, reaction, separation, detection and more involved in biological, chemical and medical analysis processes onto...view